Source: Citybizlist

Pieris: Palvella Therapeutics Closes Merger with Pieris Pharmaceuticals

WAYNE, Pa., Dec. 13, 2024 (GLOBE NEWSWIRE) - Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies... Read MoreThe post Palvella Therapeutics Closes Merger with Pieris Pharmaceuticals appeared first on citybiz.

Read full article »

Pieris's Competitors | Pieris's News | Pieris's Financials

Followers on Owler

Annual Revenue

$25-100M

Employees

1-25

President & CEO

Stephen S. Yoder

CEO Approval Rating

90/100

Pieris is a Massachusetts-based biotechnology company that develops and commercializes anticalin-derived drugs for the treatment of cancer and respiratory diseases.